OpenAI has spent the past year systematically reducing its dependence on Nvidia. The company signed a massive multi-year deal with AMD in October 2025, struck a $38 billion cloud computing agreement ...
Nearly two-thirds of Java users surveyed rely on Java for developing AI applications, with JavaML, Deep Java Library, and OpenCL being the most-used libraries.
I really wanted to believe in this free AI coding tool could replace Claude Code. But it isn't ready for prime time unless you're willing to babysit.
Caleb John (left), an investor with Pioneer Square Labs, and Lucas Dickey, a longtime entrepreneur, helped host the Claude Code Meetup in Seattle on Thursday. (GeekWire Photos / Taylor Soper) Claude ...
Replit is launching a feature that will let users create fully published and monetizable iOS apps using nothing more than natural language. It's a big step forward in the AI-first coding space, a ...
AI coding tools are rapidly changing how we produce software, and the industry is embracing it—perhaps at the expense of entry-level coding jobs. Generative AI’s ability to write software code has ...
When the creator of the world's most advanced coding agent speaks, Silicon Valley doesn't just listen — it takes notes. "If you're not reading the Claude Code best practices straight from its creator, ...
Developers are navigating confusing gaps between expectation and reality. So are the rest of us. Depending who you ask, AI-powered coding is either giving software developers an unprecedented ...
Amazon Web Services has announced a new class of AI systems," frontier agents," that can work autonomously for hours, even days, without human intervention, representing one of the most ambitious ...
The no-code movement is revolutionizing software development by allowing non-technical users to create applications without coding. Traditionally, software required extensive programming skills and ...
How a strong collaboration between clinical and billing teams can simplify J-code decoding, paving the way for improved patient access to innovative treatments. It’s an all-too-common story. A patient ...